The expression of IL-21 was shown to enhance the cytotoxicity of NKG2D CAR-NK cells against lung cancer cells in a dose-dependent manner, thereby inhibiting tumor growth both in vitro and in vivo. This evidence concerns the gene KLRK1 and lung carcinoma.